News & Updates

Find the latest news and announcements as well as our press releases and media coverage.

VANCOUVER, BC – February 28, 2024 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, announces …

VANCOUVER, BC – February 8, 2024 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, announces …

Exclusive Interview with Optimi Co-Founder & CMO, Dane Stevens By Kelly Carroll, The Fly In this edition of “Rising High,” The Fly conducted an exclusive interview with Dane Stevens, Co-Founder and Chief Marketing Officer of Optimi Health Corp. (OPTHF), a …

When we reflect on the year that has passed, we are encouraged and pleased with everything Optimi Health has achieved. Our commitment to developing psychedelic drug candidates with strict adherence to Good Manufacturing Practices (GMP) has allowed us to reach …

Dear Optimi Health Shareholders, We greatly appreciate your patience and unwavering support as we navigate the intricate landscape of building and expanding our psychedelic supply enterprise. Throughout 2023, our primary focus has remained centered in Princeton, British Columbia, Canada, operating …

VANCOUVER, BC — November 10, 2023 — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”) is pleased to announce the successful resolution of a dispute that arose in connection with a termination notice related to …

First Tranche of CAD $1,000,000 Secured From Chairman JJ Wilson’s Catcher Investments Ltd. VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian drug research and formulation company licensed by …

VANCOUVER, BC — July 27, 2023 — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”) has received a termination notice and demand for payment pursuant to a definitive supply agreement (the “Supply Agreement”) with a …

VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances such as 3,4-Methylenedioxymethamphetamine (“MDMA”), …

Dear Valued Shareholders, This is the news you’ve been waiting for. Optimi Health today announced that it has entered into a $1.2 million CAD definitive supply agreement with a private entity focused on developing mushroom-based therapeutic drugs through pre-clinical research …

Yesterday, Optimi Health announced an important MDMA and psilocybin supply agreement for Australians approved under the country’s Authorised Prescribers Scheme. Our new long-term relationship with Mind Medicine Australia positions Optimi as the primary supplier to Australia’s newly regulated psychedelic market. …

VANCOUVER, BC — January 10, 2023 — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that Mr. Bryan Safarik, Mr. Jacob Safarik, Mr. Jon Schintler, Mr. Dane Stevens, and Mr. JJ …

To Our Valued Shareholders, As 2022 draws to a close, all of us here at Optimi Health are taking a moment to reflect on the accomplishments of the past 12 months as we prepare for an impactful 2023. In that …

VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and synthetic psychedelic substances, as well as functional mushrooms …

VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushrooms for transformational human experiences, is pleased to …

VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushrooms, received a notice today from Health Canada …

Optimi CEO, Bill Ciprick, recently sat down with Investing News Network’s (INN) Stuart McNish to talk about a host of things all psychedelics and Optimi’s plan to commercialize and supply the next generation of natural psilocybin and synthetic psychedelic medicine. …

Company to maximize world-class EU-GMP operations, potentially opening future revenue-generating opportunities VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi”) or the (“Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational …

Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies. The first involves Halucenex Life Sciences Inc. owned by Australian Creso Pharma (CPH). Halucenex’s mission involves researching novel psychedelic compounds, …

By Taya Fast  Global News Magic mushrooms are now growing in Princeton, B.C., as a new mushroom research and development facility opened on Friday. Optimi Health Corp. is a Canadian-based company that grows psilocybin-producing mushrooms and functional mushrooms for clinical trials, drug companies, and …

Collaborative expertise a hallmark for future supply of natural psilocybin   VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational …

Vancouver’s Optimi Health harvests first batch of psilocybin mushrooms By Glen Korstrom Optimi Health CEO Bill Ciprick   New large psilocybin production facilities have started to pop up in B.C., providing the latest evidence that this nascent business sector is expanding …

Lab’s completion brings Company closer to full commercialization.   VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed a planned expansion of the on-site analytical …

Request to modify quantities of psilocybin and psilocin receives approval from Health Canada.   VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that a requested Amendment to its Controlled Substances Dealer’s …

To Our Valued Shareholders, Supporters, Friends and Colleagues: Big things are happening at Optimi. Thank you for being a part of them. As we’ve kicked off our year of commercialization, we’ve experienced an incredible response from backers at every level. …

VANCOUVER, British Columbia, March 08, 2022 — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is …

VANCOUVER, BC (March 1, 2022) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased …

Optimi Health to become a global leader in all-natural psilocybin production VANCOUVER, BC (February 7, 2022) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and …

VANCOUVER, BC (December 7, 2021) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional as well as novel psychedelic compounds focused on the health and wellness …

VANCOUVER, BC (October 19, 2021) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional as well as novel psychedelic compounds focused on the health and wellness …

VANCOUVER, British Columbia, August 31, 2021 — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that …

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC (GLOBE NEWSWIRE – August 18, 2021) – Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically …

VANCOUVER, BC – (August 13, 2021) – Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), announces that it has filed its condensed interim consolidated financial statements and related management discussion and analysis for the period …

VANCOUVER, BC (August 10, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, announced today that preparations for a …

VANCOUVER, BC ( July 27, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), as part of its strategic aim to fully investigate the science of mushrooms, is pleased to announce the engagement of …

VANCOUVER, BC (July 13, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products is pleased to announce its inclusion in the first psychedelics Exchange Traded Fund (“ETF”) …

VANCOUVER, BC (July 7, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products announced today that it has engaged the consulting services of Donohoe Advisory Associates LLC …

VANCOUVER, BC (June 29, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products is pleased to announce it has initiated corporate support as one of TheraPsil’s first …

VANCOUVER, BC (GLOBE NEWSWIRE – June 23, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products today announced that Thomas Finetti, partner at Charney IP Law, has …

VANCOUVER, BC (June 17, 2021) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated mushroom product developer wishes to advise it has successfully concluded uplisting to the OTCQB exchange operated by OTC …

Company Advised by Health Canada to Proceed with Phase 1 Psilocybin Study Application VANCOUVER, BC (GLOBE NEWSWIRE – June 15, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated mushroom product …

VANCOUVER, BC (June 8, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that it …

VANCOUVER, BC (GLOBE NEWSWIRE – June 3, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to …

VANCOUVER, BC – (May 25, 2021) – Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), announces that it has filed its condensed interim consolidated financial statements and related management discussion and analysis for the period …

Company welcomes leadership oversight of new product research, formulations & trials VANCOUVER, BC (GLOBE NEWSWIRE – May 26, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom …

VANCOUVER, BC (GLOBE NEWSWIRE – April 14, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to …

VANCOUVER, BC (GLOBE NEWSWIRE – April 6, 2021) — Optimi Health Corp. (CSE: OPTI) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce the …

Commercialization of All-Natural Psychedelics Targeted Through Life Sciences Expertise VANCOUVER, BC (GLOBE NEWSWIRE – March 9, 2021) — Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and …

[et_pb_section admin_label=”section”] [et_pb_row admin_label=”row”] [et_pb_column type=”4_4″][et_pb_text admin_label=”Text”] NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, — (GLOBE NEWSWIRE – November 2, 2020) – Optimi Health Corp.  (“Optimi” or the “Company”) developers of …

Get news & updates directly to your inbox.

Products do not contain psilocybin

Search
Interested In Optimi? Let's Talk.